ALK and lung cancer: At the time of diagnosis of advanced ALK+ lung cancer, 22 (28%) patients presented with intrathoracic disease only and 56 (70%) patients with extrathoracic and intrathoracic metastases at baseline, with a median of 3 metastatic sites of disease (range: 2-6).